Stock Events

Stock Events

Ocugen 

$1.49
781
-$0.36-19.46% Tuesday 20:00

Statistics

Day High
1.57
Day Low
1.48
52W High
2.48
52W Low
0.66
Volume
29,259,747
Avg. Volume
-
Mkt Cap
465.36M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.07
-0.06
-0.06
-0.05
Expected EPS
-0.051429
Actual EPS
N/A

Financials

-1,333.02%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
8.11MRevenue
-108.11MNet Income

Analyst Ratings

9Average Price Target
The highest estimate is 10.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OCGN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap17.99B
Moderna is a competitor because it focuses on mRNA technology for vaccines, including COVID-19, similar to Ocugen's focus on developing a COVID-19 vaccine.
BioNTech
BNTX
Mkt Cap24.67B
BioNTech competes directly with Ocugen in the COVID-19 vaccine space, having developed one of the first mRNA vaccines for the virus.
Novavax
NVAX
Mkt Cap1.32B
Novavax is a competitor due to its work on developing protein-based vaccines for COVID-19, offering an alternative to Ocugen's vaccine approach.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a major player in the COVID-19 vaccine market, competing with Ocugen through its collaboration with BioNTech to develop an mRNA vaccine.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson competes with Ocugen by offering a viral vector COVID-19 vaccine, providing a different technology approach in the same market.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca is in competition with Ocugen due to its viral vector vaccine for COVID-19, which is a direct alternative to Ocugen's vaccine development efforts.
Inovio Pharmaceuticals
INO
Mkt Cap89.75M
Inovio Pharmaceuticals is a competitor because it is developing DNA-based vaccines for COVID-19, positioning it as an alternative to Ocugen's vaccine technology.
Arbutus Biopharma
ABUS
Mkt Cap850.78M
Arbutus Biopharma competes with Ocugen in the broader field of biopharmaceuticals, focusing on viral diseases and vaccine technologies.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline is a competitor because it is involved in the development and distribution of vaccines, including efforts towards COVID-19, competing in the same market as Ocugen.

About

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Show more...
CEO
Dr. Shankar Musunuri M.B.A., Ph.D.
Employees
95
Country
United States
ISIN
US67577C1053

Listings

F
DE
2H51.F
STU
DE
2H51.STU
MU
DE
2H51.MU
MX
MX
OCGN.MX

0 Comments

Share your thoughts

FAQ

What is Ocugen stock price today?▼
The current price of OCGN is $1.49 USD — it has decreased by -19.46% in the past 24 hours. Watch Ocugen stock price performance more closely on the chart.
What is Ocugen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ocugen stocks are traded under the ticker OCGN.
Is Ocugen stock price growing?▼
OCGN stock has fallen by -11.31% compared to the previous week, the month change is a -15.82% fall, over the last year Ocugen has showed a +108.33% increase.
What is Ocugen market cap?▼
Today Ocugen has the market capitalization of 465.36M
When is the next Ocugen earnings date?▼
Ocugen is going to release the next earnings report on July 31, 2026.
What were Ocugen earnings last quarter?▼
OCGN earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.05 USD resulting in a -16.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ocugen revenue for the last year?▼
Ocugen revenue for the last year amounts to 8.11M USD.
What is Ocugen net income for the last year?▼
OCGN net income for the last year is -108.11M USD.
How many employees does Ocugen have?▼
As of May 06, 2026, the company has 95 employees.
In which sector is Ocugen located?▼
Ocugen operates in the Health & Wellness sector.
When did Ocugen complete a stock split?▼
The last stock split for Ocugen was on September 30, 2019 with a ratio of 1:60.
Where is Ocugen headquartered?▼
Ocugen is headquartered in Malvern, United States.